PolarityTE, Inc. operates as commercial-stage biotechnology and regenerative biomaterials company in the United States. The company focuses on discovering, designing and developing a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences. Its PolarityTE platform would be able to provide transform tissue regeneration, including potential regeneration of multiple tissue substrates, such as skin, bone, muscle, fat, cartilage, nerves, and blood vessels, as well as neural elements, solid and hollow organ composite tissue systems. The company is headquartered in Salt Lake City, Utah.
Industry, Sector and Symbol
Industry Prepackaged software
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:COOL
CUSIPN/A
Phone385-237-2279
Debt
Debt-to-Equity RatioN/A
Current Ratio12.72
Quick Ratio12.72
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual Sales$6.69 million
Price / Sales123.31
Cash FlowN/A
Price / CashN/A
Book Value$1.95 per share
Price / Book19.86
Profitability
EPS (Most Recent Fiscal Year)N/A
Net Income$-130,820,000.00
Net MarginsN/A
Return on EquityN/A
Return on Assets-189.59%
Miscellaneous
Employees33
Outstanding Shares21,300,000
Polarityte (NASDAQ:COOL) Frequently Asked Questions
What is Polarityte's stock symbol?
Polarityte trades on the NASDAQ under the ticker symbol "COOL."
How were Polarityte's earnings last quarter?
Polarityte Inc (NASDAQ:COOL) released its earnings results on Thursday, March, 16th. The company reported ($1.69) earnings per share (EPS) for the quarter. The company earned $0.16 million during the quarter. View Polarityte's Earnings History.
When is Polarityte's next earnings date?
What price target have analysts set for COOL?
1 Wall Street analysts have issued twelve-month price targets for Polarityte's shares. Their predictions range from $65.00 to $65.00. On average, they expect Polarityte's stock price to reach $65.00 in the next twelve months. View Analyst Ratings for Polarityte.
What are Wall Street analysts saying about Polarityte stock?
Here are some recent quotes from research analysts about Polarityte stock:
- 1. According to Zacks Investment Research, "PolarityTE, Inc. creates regenerative medicine and provides tissue engineering platform. It develops and obtains regulatory approval for technology which utilizes a patient's own tissue substrates for regeneration of skin, bone, muscle, cartilage and nerves. The product pipeline comprises SkinTE, OsteoTE, AngioTE, MyoTE, CarteTE, AdiposeTE and NeuralTE. PolarityTE, Inc., formerly known as Majesco Entertainment Company, is headquatered in Salt lake City, Utah. " (6/13/2018)
- 2. Cantor Fitzgerald analysts commented, ": We are reiterating our Overweight rating and lowering our PT to $65 from $70 on City facilities and the company’s recent financing. In addition to exploring the facility, management reviewed the commercial progress for SkinTE and the development pipeline. Following a recent financing in June, Polarity looks well-positioned to deliver on its objectives over the next 24 months, which we describe in this note. We provide a model update to account for the recent raise." (6/12/2018)
Are investors shorting Polarityte?
Polarityte saw a increase in short interest during the month of May. As of May 15th, there was short interest totalling 2,081,897 shares, an increase of 56.8% from the April 30th total of 1,327,769 shares. Based on an average trading volume of 570,757 shares, the days-to-cover ratio is presently 3.6 days. Currently, 31.0% of the shares of the stock are short sold. View Polarityte's Current Options Chain.
Who are some of Polarityte's key competitors?
Some companies that are related to Polarityte include Manhattan Associates (MANH), CommVault Systems (CVLT), ACI Worldwide (ACIW), Cornerstone OnDemand (CSOD), Mongodb (MDB), Mimecast (MIME), Q2 (QTWO), BlackLine (BL), Cogent Communications (CCOI), Descartes Systems Group (DSGX), Alteryx (AYX), Sailpoint Technologies (SAIL), Varonis Systems (VRNS), Appian (APPN) and Cyberark Software (CYBR).
Who are Polarityte's key executives?
Polarityte's management team includes the folowing people:
- Mr. John Stetson, CFO, Exec. VP, Sec. & Director (Age 33)
- Dr. Denver M. Lough, Chairman, CEO & Chief Scientific Officer (Age 37)
- Dr. Edward Winslow Swanson M.D., COO & Director (Age 33)
- Mr. Rich Haerle, VP of Investor Relations & Strategy
- Mr. Cameron J. Hoyler J.D., Gen. Counsel (Age 34)
Has Polarityte been receiving favorable news coverage?
Media coverage about COOL stock has been trending somewhat positive this week, Accern Sentiment Analysis reports. The research firm ranks the sentiment of news coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Polarityte earned a coverage optimism score of 0.16 on Accern's scale. They also gave media coverage about the company an impact score of 46.22 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the near term.
Who are Polarityte's major shareholders?
Polarityte's stock is owned by a number of of institutional and retail investors. Top institutional investors include BRAUSER MICHAEL (8.58%) and Suntrust Banks Inc. (0.05%). Company insiders that own Polarityte stock include Barry C Honig, Edward Winslow Swanson, Jeffrey Hansen Dyer, John Stetson and Michael Martin Beeghley. View Institutional Ownership Trends for Polarityte.
Which major investors are buying Polarityte stock?
COOL stock was purchased by a variety of institutional investors in the last quarter, including Suntrust Banks Inc.. Company insiders that have bought Polarityte stock in the last two years include Barry C Honig, Edward Winslow Swanson, Jeffrey Hansen Dyer, John Stetson and Michael Martin Beeghley. View Insider Buying and Selling for Polarityte.
How do I buy shares of Polarityte?
Shares of COOL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Polarityte's stock price today?
One share of COOL stock can currently be purchased for approximately $38.73.
How big of a company is Polarityte?
Polarityte has a market capitalization of $830.23 million and generates $6.69 million in revenue each year. Polarityte employs 33 workers across the globe.
How can I contact Polarityte?
Polarityte's mailing address is 1960 S 4250 W, SALT LAKE CITY UT, 84104. The company can be reached via phone at 385-237-2279 or via email at [email protected]
MarketBeat Community Rating for Polarityte (COOL)
MarketBeat's community ratings are surveys of what our community members think about Polarityte and other stocks. Vote "Outperform" if you believe COOL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe COOL will underperform the S&P 500 over the long term. You may vote once every thirty days.
